George is a seasoned Business Executive, that has led over $50M of business deals and transactions and generated over $70M+ of revenue over his career. George has demonstrated the ability to build multi-million dollar businesses in Technology and E-commerce, through his leadership as CEO of Navigating The Curve, President of Live Out There and his years as a Client Executive at IBM Canada. Skilled in creating organizational alignment and building Advanced Sales Funnel / Deal management systems. Leading industry experience in Digital Strategy, E-Commerce and Retail. Strong entrepreneurship professional with a Bachelor of Commerce (BComm) from The University of Calgary.

25-plus years of experience in finance, sales and corporate strategy, with a strong background in health care, business services and technology. Prior to joining NetraMark, Mr. Spiegel was the vice-president of business strategy at VeraSci, where he leveraged his experience to provide strategic planning and oversight of commercial operations, including the launch of the Pathway eClinical platform and positioned the company for a highly successful $330-million (U.S.) exit to WCG Clinical, a leader in the pharmaceutical services sector.

Dr Joseph Geraci, PhD is a mathematician, medical scientist, and quantum machine learning specialist. He holds postdocs in machine learning, oncology and neuropsychiatry. He has developed novel machine intelligence algorithms that are capable of providing extraordinary insights into complex data sets, like those found in clinical trials.

He is associated with the department of Molecular Medicine and Pathology at Queen's University in Ontario, Canada, and the Centre for Biotechnology and Genomics Medicine Medical College of Georgia, USA.

Daniel Gallucci, Co-founder and Chief Performance Officer of Nurosene, is a trained functional neurologist, osteopath, and brain researcher. His clinical experience ranges from professional athletes to those with neurodegenerative disease and virtually everyone in between. A personal brain cancer diagnosis in 2009 further fuelled his obsession with peeking behind the curtain and better understanding how the brain functions in both sickness and health.

Dr. Luca Pani, Chief Innovation and Regulatory Officer, was the former Director General of the Italian Medicines Agency. VP for Regulatory Strategy and Market Access Innovation at VeraSci, Professor of Psychiatry and Clinical Pharmacology, and author of over 180 scientific publications.

D.J. Cook MD, PhD is a neurosurgeon and neuroscientist at Queen's University where he is Division Head and Chair of Neurosurgery. Dr. Cook completed his MD, PhD and residency at the University of Toronto and undertook fellowship training at Stanford University in Cerebrovascular and Skull Base Surgery. Dr. Cook's present research is focused on the development of predictive imaging, physiological and behavioural biomarkers in stroke and traumatic brain injury. His work includes the use of multi-sequence MRI analysis using artificial intelligence algorithms to derive novel insights into mechanisms of disease and to monitor recovery and therapy. Throughout his career, Dr. Cook has utilized research methodologies to validate and model therapeutic strategies in stroke and traumatic brain injury with numerous industry partners.

Swapan Kakumanu, CFO, brings over 25+ years of senior finance and operations experience. Mr. Kakumanu has served at senior executive management levels, both in public and private companies in high growth technology, manufacturing, trading and oil field services industries, having held senior roles as President, Chief Executive Officer, Chief Financial Officer, Company Secretary and served on Boards of some of these Companies. Swapan brings extensive experience in public company reporting, investor relations, mergers and acquisitions, internal controls and general overall financial and operational management.